Act Now

Write Letters to Ask for Approval of New Neurogenic Orthostatic Hypotension Treatments

Your personal letters to the U.S. Food and Drug Administration (FDA), and Congress are a great way to bring attention to the need for new treatments for patients suffering from neurogenic orthostatic hypotension (neurogenic OH or nOH). It is easy to compose your letter — click on the appropriate icon below for patient, health care provider, caregiver or patient advocate to start your letter.